Cigna Investments Inc Biomarin Pharmaceutical Inc Transaction History

Cigna Investments Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$80.93 - $108.63 $164,368 - $220,627	2,031 New	2,031 $210,000
Q3 2020 Nov 12, 2020	SELL	$71.87 - $131.03 $132,887 - $242,274	-1,849 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$79.55 - $124.22 $147,087 - $229,682	1,849 New	1,849 $228,000
Q4 2018 Feb 06, 2019	SELL	$80.14 - $106.07 $180,795 - $239,293	-2,256 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$76.01 - $99.03 $171,478 - $223,411	2,256 New	2,256 $213,000
Q4 2017 Jan 26, 2018	SELL	$80.76 - $95.13 $184,536 - $217,372	-2,285 Closed	0 $0
Q3 2017 Oct 11, 2017	BUY	$80.6 - $94.95 $184,171 - $216,960	2,285	2,285 $213,000

632

185M

1.63M

1.2M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Cigna Investments Inc , based on Form 13F filings with the SEC.

Stay updated on Cigna Investments Inc with notifications on news.